Kiromic BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KRBP and buy or sell other stocks, ETFs, and their options commission-free!About KRBP
Kiromic Biopharma, Inc. is a clinical stage biotherapeutics company, which engages in DIAMOND AI and discovers, validates, and develops cell and gene therapies with a therapeutic focus on immuno-oncology. The firm is in the process of developing ALEXIS, a multi-indication allogeneic CAR-T cell therapy platform that exploits the natural potency of gamma delta T-cells to target solid cancers.
CEOPietro Bersani, CPA
CEOPietro Bersani, CPA
Employees—
Employees—
HeadquartersHouston, Texas
HeadquartersHouston, Texas
Founded2006
Founded2006
Employees—
Employees—
KRBP Key Statistics
Market cap200.00
Market cap200.00
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume27.50
Average volume27.50
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.1238
52 Week high$0.1238
52 Week low—
52 Week low—
Stock Snapshot
As of today, Kiromic BioPharma(KRBP) shares are valued at $0.00. The company's market cap stands at 200.
On 2026-05-05, Kiromic BioPharma(KRBP) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Kiromic BioPharma(KRBP) stock has reached 0, versus its average volume of 27.5.
People also own
Based on the portfolios of people who own KRBP. This list is generated using Robinhood data, and it’s not a recommendation.